Green D M, Beckwith J B, Weeks D A, Moksness J, Breslow N E, D'Angio G J
Department of Pediatrics, Roswell Park Cancer Institute, Buffalo, NY 14263.
Cancer. 1994 Sep 15;74(6):1817-20. doi: 10.1002/1097-0142(19940915)74:6<1817::aid-cncr2820740626>3.0.co;2-x.
The purpose of this study was to determine the relationship between histologic microsubstaging variables, patient age, and tumor specimen weight in patients with Stage I/favorable histology Wilms' tumors.
The authors reviewed all randomized patients from the Fourth National Wilms' Tumor Study, who had Stage I/favorable histology Wilms' tumors evaluated for one or more of the microsubstaging variables: (1) the presence of an inflammatory pseudocapsule, (2) renal sinus invasion, (3) tumor in the intrarenal vessels, and (4) tumor capsule invasion. The authors determined the correlation between microsubstaging variables and age at diagnosis or tumor specimen weight.
Patients who were younger than 2 years of age at diagnosis were significantly more likely to have all negative microsubstaging variables. Patients who had tumors weighing less than 550 g were more likely to have all negative microsubstaging variables. However, neither renal sinus invasion nor tumor in the intrarenal vessels was more frequent in tumors weighing more than 550 g.
An age at diagnosis of younger than 2 years and a tumor specimen weight of less than 550 g are highly correlated with the absence of adverse microsubstaging variables. The clinical variables of age at diagnosis and tumor specimen weight, compared with the assessment of microsubstaging variables, have the practical advantage of being more objectively determined and not requiring a central pathologic review for confirmation.
本研究的目的是确定I期/楼组织学类型的肾母细胞瘤患者的组织学微分期变量、患者年龄和肿瘤标本重量之间的关系。
作者回顾了第四届全国肾母细胞瘤研究中所有随机分组的患者,这些患者患有I期/楼组织学类型的肾母细胞瘤,并对以下一个或多个微分期变量进行了评估:(1)炎性假包膜的存在;(2)肾窦侵犯;(3)肾内血管内肿瘤;(4)肿瘤包膜侵犯。作者确定了微分期变量与诊断时年龄或肿瘤标本重量之间的相关性。
诊断时年龄小于2岁的患者更有可能所有微分期变量均为阴性。肿瘤重量小于550g的患者更有可能所有微分期变量均为阴性。然而,在重量超过550g的肿瘤中,肾窦侵犯和肾内血管内肿瘤的发生率并没有更高。
诊断时年龄小于2岁和肿瘤标本重量小于550g与不存在不良微分期变量高度相关。与微分期变量评估相比,诊断时年龄和肿瘤标本重量这些临床变量具有更客观确定且无需中央病理复查确认的实际优势。